Skip to main content
. 2016 Jun 28;353:i3365. doi: 10.1136/bmj.i3365

Table 2.

Comorbid conditions and comedications at time of event in two nested case-control studies. Differences in comorbid conditions and comedications between outcome groups, combined with data on degree of alendronate exposure, drive conditional logistic regression analyses in subsequent tables. Figures are numbers (percentage) of patients unless specified otherwise

Subtrochanteric and femoral shaft fracture Hip fracture
Cases (n=1428) Controls (n=6825) P value Cases (n=6784) Controls (n=19 952) P value
Mean (SD) age (years) 79.6 (9.4) 79.7 (9.4) NA* 80.2 (8.9) 80.1 (8.8) NA*
Women 1258 (88.1) 6056 (88.7) NA* 5980 (88.1) 17 605 (88.1) NA*
Charlson index:
 0 409 (28.6) 2530 (37.1) <0.001 2092 (30.8) 7504 (37.6) <0.001
 1 102 (7.1) 442 (6.5) 514 (7.6) 1475 (7.4)
 2 323 (22.6) 1593 (23.3) 1485 (21.9) 4573 (22.9)
 ≥3 594 (41.6) 2260 (33.1) 2693 (39.7) 6400 (32.1)
Main comorbid conditions:
 Any fracture 1091 (76.4) 3447 (50.5) <0.001 4287 (63.4) 9061 (45.9) <0.001
 Major osteoporotic fracture 987 (69.1) 2967 (43.5) <0.001 3778 (55.8) 7709 (39.1) <0.001
 Fracture of pelvis, femur, or lower leg 364 (25.5) 1034 (15.2) <0.001 1260 (18.6) 2547 (12.9) <0.001
 Diabetes 125 (8.8) 400 (5.9) <0.001 496 (7.3) 1204 (6.1) <0.001
 Chronic kidney disease 25 (1.8) 74 (1.1) 0.04 125 (1.8) 248 (1.3) <0001
 Chronic pulmonary disease 325 (22.8) 1382 (20.2) 0.03 1497 (22.1) 4001 (20.3) 0.001
 Previous myocardial infarction 144 (10.1) 541 (7.9) 0.008 648 (9.6) 1726 (8.7) 0.04
Drug history (in past year):
Prednisolone 252 (17.6) 1336 (19.6) 0.10 1255 (18.5) 4146 (20.8) <0.001
Proton pump inhibitors 483 (33.8) 1948 (28.5) <0.001 2226 (32.8) 5488 (27.5) <0.001
Thiazides 350 (24.5) 1751 (25.7) 0.38 1762 (26.0) 5187 (26.0) 0.97

*Age and sex matched analysis, P values not calculated.